EuroGCT (2021-2025)
European Consortium for Communicating Gene and Cell Therapy Information
PI: C. Blackburn, Centre for Regenerative Medicine, The University of Edinburgh
Project Deputies: Aurélie Mahalatchimy, UMR 7318 DICE CERIC, and Andreas Kurtz, IBMT
The European Consortium for Communicating Gene and Cell Therapy Information (EuroGCT) is a five years research project which has two major objectives:
- To provide patients, people affected by conditions, healthcare professionals and citizens with accurate scientific,legal, ethical and societal information and with engagement opportunities, and thus to support better informeddecision-making related to cell and gene-based therapies.
- To facilitate better decision-making at key points in development of new therapies and thus enable improved productdevelopment, by providing the research community and regulatory and healthcare authorities with an informationsource on the practical steps needed for cell and gene therapy development.
To achieve these aims, EuroGCT will adopt a highly structured system for coordinated management of information related to cell and gene therapy development and, from this, will implement an ambitious programme of online and direct stakeholder information provision and engagement. All outputs will be delivered in 7 European languages, to ensure broad accessibility, and will be rigorously evaluated against measurable objectives throughout the project duration.